Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
1(33%)
Results Posted
0%(0 trials)
Terminated
1(33%)

Phase Distribution

Ph not_applicable
2
67%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

3

all time

Status Distribution
Active(1)
Completed(1)
Terminated(1)

Detailed Status

Completed1
Terminated1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
1
Success Rate
50.0%
Most Advanced
N/A

Trials by Phase

N/A2 (100.0%)

Trials by Status

completed133%
terminated133%
recruiting133%

Recent Activity

1 active trials
Showing 3 of 3
recruiting

Characterization of Acute Myocardial Damage With Spectral Computed Tomography. (CADAMI-SPECTRAL)

NCT06506071
terminatednot_applicable

Spectral CT Clinical Trial Protocol

NCT05017233
completednot_applicable

Cerebral Dynamic Perfusion Study With Spectral CT in Patients Suspected of Stroke

NCT03948425

Clinical Trials (3)

Showing 3 of 3 trials
NCT06506071

Characterization of Acute Myocardial Damage With Spectral Computed Tomography. (CADAMI-SPECTRAL)

Recruiting
NCT05017233Not Applicable

Spectral CT Clinical Trial Protocol

Terminated
NCT03948425Not Applicable

Cerebral Dynamic Perfusion Study With Spectral CT in Patients Suspected of Stroke

Completed

All 3 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
3